EUTM file information

002122893

KAPTUR


March 8, 2001

Trademark Summary

The trademark KAPTUR was filed by Pfizer Enterprises SARL, a corporation established under the laws of the Grand Duchy of Luxembourg (the "Applicant"). The application was published for oppositions on October 14, 2001, and received undefined oppositions.

Opposition Proceedings

There are undefined Oppositions claimed against trademark.

The first opposition filed on January 14, 2002 by null on Likelihood of confusion. and its proceedings were handled in English The second opposition filed on January 9, 2002 by Byk Gulden Lomberg Chemische Fabrik GmbH on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. and its proceedings were handled in English

The application was filed in Italian, and Italian was also language of all opposition proceedings (English was selected as the second language).

Change of name and address of the trademark registration was recorded on October 30, 2001. Change of name and professional address of the trademark registration was recorded on July 7, 2002. Appointment and Replacement of representative of the trademark registration was recorded on January 8, 2004. Change of name and address of the trademark registration was recorded on March 24, 2006. Change of name and professional address of the trademark registration was recorded on July 1, 2007. Change of name and address of the trademark registration was recorded on July 1, 2007. Appointment and Replacement of representative of the trademark registration was recorded on September 2, 2007. Appointment and Replacement of representative of the trademark registration was recorded on May 3, 2009. Appointment and Replacement of representative of the trademark registration was recorded on October 9, 2012.

The Opposition with reference B 000474546 was refused according to Article 8(1)(b) CTMR with decision issued on July 22, 2004 by the EUIPO.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparations for the prevention and treatment of cancers.